HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Julio García-Suárez Selected Research
Julio García-Suárez Research Topics
Disease
5
Neoplasms (Cancer)
11/2021 - 01/2003
3
Lymphoma (Lymphomas)
04/2024 - 01/2002
3
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2023 - 09/2005
3
Infections
11/2021 - 01/2003
2
Thrombosis (Thrombus)
04/2024 - 01/2016
2
COVID-19
01/2024 - 10/2020
2
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2024 - 11/2021
2
Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2020 - 03/2010
2
Hematologic Neoplasms (Hematological Malignancy)
10/2020 - 09/2005
2
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2013 - 01/2007
2
Pneumonia (Pneumonitis)
03/2010 - 01/2002
1
Multiple Myeloma
04/2024
1
Invasive Fungal Infections
11/2021
1
Lymphopenia (Lymphocytopenia)
11/2021
1
Heart Diseases (Heart Disease)
03/2021
1
Confusion (Bewilderment)
03/2021
1
Chronic Renal Insufficiency
03/2021
1
Sepsis (Septicemia)
01/2016
1
Human Influenza (Influenza)
03/2010
1
Acute Kidney Injury (Acute Renal Failure)
12/2008
1
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
12/2005
1
Communicable Diseases (Infectious Diseases)
12/2005
1
Hodgkin Disease (Hodgkin's Disease)
12/2005
1
Progressive Multifocal Leukoencephalopathy
12/2005
1
Peritonitis
09/2005
1
Chemotherapy-Induced Febrile Neutropenia
01/2003
1
Neutropenia
01/2003
1
Fever (Fevers)
01/2003
1
Hemolysis
06/2002
1
Aplastic Anemia (Anemia, Hypoplastic)
01/2002
1
Hepatitis
01/2002
1
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2002
Drug/Important Bio-Agent (IBA)
4
Rituximab (Mabthera)
FDA Link
11/2021 - 12/2005
3
Cyclophosphamide (Cytoxan)
FDA Link
Generic
02/2013 - 01/2002
2
Dexamethasone (Maxidex)
FDA Link
Generic
04/2024 - 02/2013
2
Monoclonal Antibodies
IBA
11/2021 - 10/2020
2
Antineoplastic Agents (Antineoplastics)
IBA
10/2020 - 12/2005
2
Prednisone (Sone)
FDA Link
Generic
02/2013 - 01/2007
2
Vincristine (Oncovin)
FDA Link
Generic
02/2013 - 01/2007
2
Doxorubicin (Adriamycin)
FDA Link
Generic
02/2013 - 01/2007
2
Etoposide (VP 16)
FDA Link
Generic
02/2013 - 01/2007
1
Factor VIII (Coagulation Factor VIII)
IBA
04/2024
1
Protein S
IBA
04/2024
1
fibrin fragment D (D-dimer)
IBA
04/2024
1
Biomarkers (Surrogate Marker)
IBA
04/2024
1
factor V Leiden
IBA
04/2024
1
Factor XIII (Coagulation Factor XIII)
IBA
04/2024
1
nirmatrelvir and ritonavir drug combination
IBA
01/2024
1
N-methyl-valyl-amiclenomycin (BA 2)
IBA
01/2024
1
remdesivir
IBA
01/2024
1
N-(2-cyanoethylene)urea (BA 1)
IBA
01/2024
1
acalabrutinib
IBA
11/2021
1
ofatumumab
FDA Link
11/2021
1
obinutuzumab
IBA
11/2021
1
ibrutinib
IBA
11/2021
1
idelalisib
IBA
11/2021
1
venetoclax
IBA
11/2021
1
pembrolizumab
IBA
11/2021
1
Nivolumab
IBA
11/2021
1
Urea (Carbamide)
FDA Link
Generic
03/2021
1
Antiviral Agents (Antivirals)
IBA
10/2020
1
Methotrexate (Mexate)
FDA Link
Generic
12/2008
1
purine
IBA
12/2005
1
Alkylating Agents
IBA
12/2005
1
Anti-Bacterial Agents (Antibiotics)
IBA
06/2002
1
Cyclosporine (Ciclosporin)
FDA Link
Generic
01/2002
1
Antilymphocyte Serum (Anti-Thymocyte Globulin)
IBA
01/2002
Therapy/Procedure
7
Drug Therapy (Chemotherapy)
05/2023 - 01/2003
6
Therapeutics
10/2020 - 06/2002
1
Stem Cell Transplantation
01/2024
1
Catheters
01/2016
1
Radiotherapy
12/2005
1
Organ Transplantation
09/2005
1
Continuous Ambulatory Peritoneal Dialysis (CAPD)
09/2005
1
Induction Chemotherapy
06/2002
1
Aftercare (After-Treatment)
01/2002